Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

S Mirzaei, MK Mahabady, A Zabolian, A Abbaspour… - Life Sciences, 2021 - Elsevier
Glioblastoma multiforme (GBM) is one of the worst brain tumors arising from glial cells,
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …

Pathological roles of the homeostatic chemokine CXCL12

R Janssens, S Struyf, P Proost - Cytokine & growth factor reviews, 2018 - Elsevier
CXCL12 is a CXC chemokine that traditionally has been classified as a homeostatic
chemokine. It contributes to physiological processes such as embryogenesis, hematopoiesis …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency

OM Kutova, EL Guryev, EA Sokolova, R Alzeibak… - Cancers, 2019 - mdpi.com
Malignant tumors are characterized by structural and molecular peculiarities providing a
possibility to directionally deliver antitumor drugs with minimal impact on healthy tissues and …

Nucleic acid-based approaches for tumor therapy

S Hager, FJ Fittler, E Wagner, M Bros - Cells, 2020 - mdpi.com
Within the last decade, the introduction of checkpoint inhibitors proposed to boost the
patients' anti-tumor immune response has proven the efficacy of immunotherapeutic …

Advances in chemokine signaling pathways as therapeutic targets in glioblastoma

RM Urbantat, P Vajkoczy, S Brandenburg - Cancers, 2021 - mdpi.com
Simple Summary Chemokine signaling is crucial for tumorigenesis, proliferation,
angiogenesis, tumor progression and metastasis in glioblastoma. Furthermore, chemokines …

Reactive oxygen species (ROS)-responsive nanomedicine for RNAi-based cancer therapy

Y Li, H Bai, H Wang, Y Shen, G Tang, Y Ping - Nanoscale, 2018 - pubs.rsc.org
Although much effort has been dedicated to the development of efficient siRNA delivery for
cancer therapy, delivery nanomaterials that can particularly respond to reactive oxygen …

Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle

Y Yang, Y Meng, J Ye, X Xia, H Wang, L Li… - Journal of Controlled …, 2018 - Elsevier
Co-delivery of chemotherapy drugs and VEGF siRNA (siVEGF) to control tumor growth has
been a research hotspot for improving cancer treatment. Current systems co-deliver siVEGF …

RNA interference and nanotechnology: A promising alliance for next generation cancer therapeutics

G Swaminathan, A Shigna, A Kumar… - Frontiers in …, 2021 - frontiersin.org
Cancer is a significant health hazard of the 21st century, and GLOBOCAN predicts
increasing cancer incidence in the coming decades. Though several conventional treatment …

Recent emerging immunological treatments for primary brain tumors: focus on chemokine-targeting immunotherapies

A Ardizzone, R Basilotta, A Filippone, L Crupi, M Lanza… - Cells, 2023 - mdpi.com
Primary brain tumors are a leading cause of death worldwide and are characterized by
extraordinary heterogeneity and high invasiveness. Current drug and radiotherapy therapies …